CORPORATE GOVERNANCE

Dr. Garnier is an Operating Partner at Advent International (global private equity). He served as CEO of Pierre Fabre SA from 2008 to 2010 and as CEO and Executive Member of the Board of Directors of GlaxoSmithKline plc from 2000 to 2008. Dr. Garnier served as CEO of SmithKline Beecham plc in 2000, and as Chief Operating Officer and Executive Member of the Board of Directors from 1996 to 2000. Dr. Garnier is Chairman of the Board of Cellectis S.A., and was a director of Carmat, where he served as non-executive Chairman, from 2018 to 2022, Radius Health, Inc. from 2015 to 2022, United Technologies Corporation from 1997 to the separation in 2020 and Actelion Ltd., where he served as non-executive Chairman, from 2011 to 2017. He served as non-executive Chairman of the Board of Idorsia Pharmaceuticals Ltd. from 2017 to 2020, as a director of Alzheon, Inc. (non-public) from 2015 to 2018 and as a director of Renault S.A. (public) from 2009 to 2016. Dr. Garnier is on the Advisory Board of Newman’s Own Foundation; he is a Knight Commander of the Order of the British Empire and Officier de la Légion d’Honneur of France and was a board member of the Max Planck Institute from 2013 to 2019. Dr. Garnier holds a master’s degree and Ph.D. from Louis Pasteur University and an MBA from Stanford University.